3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(ADP-ribose)polymerase (PARP) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis
Details for Australian Patent Application No. 2005297570 (hide)
International Classifications
Event Publications
17 May 2007 PCT application entered the National Phase
PCT publication WO2006/042638 Priority application(s): WO2006/042638
16 June 2011 Application Accepted
Published as AU-B-2005297570
27 October 2011 Amendment Made
The nature of the amendment is: Amend the invention title to read 3,6-substituted 5-arylamino-1H-pyridine-2-one derivatives and related compounds as poly(ADP-ribose)polymerase (PARP) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis 2006
3 November 2011 Standard Patent Sealed
7 June 2012 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 21 Jun 2011
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser